Steven G. Davis is a partner with McCarter & English, LLP. Dr. Davis is a member of the Intellectual Property and Information Technology practice group.
Dr. Davis' practice focuses on patent prosecution, portfolio strategy and management, freedom to operate assessments, infringement analysis, patent issues related to IPOs, and intellectual property licensing. He assists universities, start-ups, and major pharmaceutical corporations with protecting technologies in the areas of chemistry, pharmaceuticals, and biotechnology, with a particular emphasis in organic chemistry. Of particular interest is advising venture capital investors with due diligence investigations and advising other clients prior to acquiring intellectual property assets.
Dr. Davis has practiced patent law for 18 years both in private practice and as in-house patent counsel for Eli Lilly & Co. His clients also benefit from his experience in industry as a research scientist.
Dr. Davis has co-authored eight scientific publications and is a co-inventor on U.S. Patent 5,073,564 covering photo activated insecticides. After completing graduate school, he worked for five years conducting research in the areas of pesticide chemistry and the preparation of compounds containing stable isotopes. Dr. Davis is committed to the promotion of early-stage technologies.
Dr. Davis has been recognized as a Chambers USA "Leaders in their Field" lawyer for 2010, 2012, 2013 and 2014. According to the latest edition, Dr. Davis is a highly experience patent prosectuor, with a well-established practice prosecuting patents for the pharmaceautical industry. Clients also attest that he is "autonomous, thorough and thoughtful."